DNAPrint Genomics Analysis

DNAPrint Stock Analysis Notes

The company recorded a loss per share of 0.01. DNAPrint Genomics had not issued any dividends in recent years. The entity had 0.05:1 split on the 12th of July 2005. DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany. DNAPRINT GENOMICS is traded on OTC Exchange in the United States. To learn more about DNAPrint Genomics call the company at 941-366-3400.

DNAPrint Genomics Investment Alerts

DNAPrint Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 644.

DNAPrint Profitablity

The company has Profit Margin (PM) of (2.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.31.

DNAPrint Genomics Outstanding Bonds

Stock analysis is the technique used by a trader or investor to examine and evaluate how DNAPrint Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DNAPrint shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as DNAPrint Genomics. By using and applying DNAPrint Stock analysis, traders can create a robust methodology for identifying DNAPrint entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

If you are still planning to invest in DNAPrint Genomics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DNAPrint Genomics' history and understand the potential risks before investing.